Tema GLP-1, Obesity & Cardiometabolic ETF
Dawn Global Topco Ltd. HRTS ETF
HRTS Price | $29.195 |
Market Cap | $75.89M |
Annual Dividend Yield | 0.47% |
Annual Dividend | $0.14 |
Yearly Management Fee | 0.75% |
Asset Class | Equity |
Focus | Health care |
Category | Sector, Health Care |
Niche | Pharma, biotech & life sciences |
Last 24h Volume | $12.07K |
Portfolio Management Company | Dawn Global Topco Ltd. |
Discount/Premium to NAV | -0.15% |
Inception Date | Nov 21, 2023 |
Market Cap Rank | 2188 |
Monthly AUM Growth | -1.17% |
Holdings Region | Global |
Management Style | Active |
Leverage | Non-Leveraged |
Tema GLP-1, Obesity & Cardiometabolic ETF is an ETF issued by Dawn Global Topco Ltd. on Nov 21 2023.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of HRTS ETF according to its net asset value is discounted at -0.15%.
While the total value of the fund shows $-894,780 decrease compared to the previous month, its price is traded daily at a decrease of -4.28%.
The annual dividend yield of HRTS ETF is 0.47%, whereas its main asset area is Global.
HRTS ETF, whose 24-hour total volume is $12.07K, has experienced a $0 cash outflow in the last month.
In addition, Tema GLP-1, Obesity & Cardiometabolic ETF's one-year net asset value total return is 4.64%.
HRTS ETF Returns
Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
-4.28% |
-9.50% |
-5.21% |
-17.27% |
-9.95% |
-4.62% |
-0.36% |
HRTS ETF NAV Total Return
Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
1.70% |
-12.10% |
1.65% |
4.64% |
17.08% |
17.08% |
HRTS ETF Fund Flows Chart
HRTS ETF Market Cap Chart
HRTS ETF NAV Growth Chart
HRTS ETF Comments
no comments yet